The aim of our study was to estimate the levels of @entity6421 (NTP), anti thyroglobulin antibodies (ATG), anti thyroid microsomal antibodies (MAB), immunoglobulins (IgG, IgA and IgM) and @entity1011 in the serum of @entity1 with @entity1374 . The clinical material consisted of 71 @entity1 (64 @entity1 and 7 @entity1 ) with @entity137 (30 @entity1 ), @entity5 (33 @entity1 : 22 with @entity259 and 11 with @entity259 ) and @entity1374 (8 @entity1 ). The control group consisted of 30 healthy @entity1 . In studied groups the mean serum levels of NTP and @entity1011 were in normal range. The highest levels of NTP were found in @entity1 with @entity259 (7.14 +/- 5.95 nmol/l) and with @entity137 (5.13 +/- 3.57 nmol/l). It was statistically significant in comparison with control group (p < 0.05). Anti thyroglobulin antibodies (ATG) were detected in serum of 36 @entity1 (50.7%) and anti thyroid microsomal antibodies (MAB) were in serum of 28 @entity1 (39.4%). Mean levels of these autoantibodies were significantly higher than in control group (< 0.05). In @entity1 with autoantibodies (ATG and/or MAB) mean serum level of NPT was significantly higher than in @entity1 without these autoantibodies (p < 0.05). We did not find a significant correlation between the level of NPT and the levels of ATG and MAB.

[Level of @entity6421 in blood serum in selected XXXX ].

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'persons', 'men'] @entity137 :: ('MESH:D064420', 'Disease') :: ['non-toxic nodular goitre'] @entity6421 :: ('MESH:D019798', 'Chemical') :: ['neopterin'] @entity5 :: ('MESH:D009369', 'Disease') :: ['neoplasms'] @entity1011 :: ('MESH:D003404', 'Chemical') :: ['creatinine'] @entity259 :: ('MESH:D013964', 'Disease') :: ['thyroid carcinoma', 'thyroid adenoma'] @entity1374 :: ('MESH:D013959', 'Disease') :: ['thyroiditis', 'thyroid diseases']
@entity1374 :: (MESH:D013959,Disease) :: ['thyroid diseases']
